Effects of donepezil on motor function in patients with Alzheimer disease [8]

Journal of Clinical Psychopharmacology

Volumn 24, Issue 3, 2004, Pages 354-356

  Bohnen, Nicolaas ^a   Kaufer, Daniel ^a   Hendrickson, Rick ^a   Ivanco, Larry ^a   Moore, Robert ^a   DeKosky, Steven ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL;

AGED; ALZHEIMER DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; FEMALE; HANDWRITING; HUMAN; KINEMATICS; LETTER; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; PARKINSON DISEASE; PRIORITY JOURNAL; RATING SCALE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; FEMALE; HUMANS; INDANS; MALE; MIDDLE AGED; MOTOR SKILLS; PIPERIDINES;

EID: 2442654107     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000126665.88905.6a     Document Type: Letter

References (11)

1. Hegerl U, Mergl R, Henkel V, et al. Kinematic analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer dementia. J Clin Psychopharmacol. 2003;23:214-216.
2. Bourke D, Druckenbrod RW. Possible association between donepezil and worsening Parkinson's disease. Ann Pharmacother. 1998;32:610-611.
3. Shea C, MacKnight C, Rockwood K. Donepezil for treatment of dementia with Lewy bodies: a case series of nine cases. Int Psychogeriatr. 1998;10:229-238.
4. Carcenac D, Martin-Hunyadi C, Kiesmann M, et al. Extra-pyramidal syndrome induced by donepezil. Presse Med. 2000;29:992-993.
5. Fabbrini G, Barbanti P, Aurilia C, et al. Donepezil in the treatment of hallucinations and delusions in Parkinson's disease. Neurol Sci. 2002;23:41-43.
6. Kaufer DI, Catt KE, Lopez OL, et al. Dementia with Lewy bodies: response of delirium-like features to donepezil. Neurology. 1998;51:1512.
7. Lezak M. Neuropsychological Assessment. New York, NY: Oxford University Press; 1995.
8. Fahn S, Elton R. Members of the UPDRS development committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden C, Calne D, eds., et al. Recent Developments in Parkinson's Disease. Florham Park, NJ: Macmillan Healthcare Information; 1987:153-164.
9. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
10. Langlais PJ, Thal L, Hansen L, et al. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies. Neurology. 1993;43:1927-1934.
11. Volkow ND, Ding Y-S, Fowler JS, et al. Dopamine transporters decrease with age in healthy subjects. J Nucl Med. 1996;37:554-558.